925 related articles for article (PubMed ID: 9189125)
1. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
2. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
[TBL] [Abstract][Full Text] [Related]
4. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
Neumann DR; Esselstyn CB; Go RT; Wong CO; Rice TW; Obuchowski NA
AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
7. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings.
Nichols KJ; Tomas MB; Tronco GG; Rini JN; Kunjummen BD; Heller KS; Sznyter LA; Palestro CJ
Radiology; 2008 Jul; 248(1):221-32. PubMed ID: 18483228
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
9. Sestamibi parathyroid imaging.
McBiles M; Lambert AT; Cote MG; Kim SY
Semin Nucl Med; 1995 Jul; 25(3):221-34. PubMed ID: 7570042
[TBL] [Abstract][Full Text] [Related]
10. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123.
Hindié E; Mellière D; Jeanguillaume C; Perlemuter L; Chéhadé F; Galle P
J Nucl Med; 1998 Jun; 39(6):1100-5. PubMed ID: 9627353
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pinhole and SPECT 99mTc-MIBI imaging in primary hyperparathyroidism.
Ho Shon IA; Yan W; Roach PJ; Bernard EJ; Shields M; Sywak M; Sidhu S; Delbridge LW
Nucl Med Commun; 2008 Nov; 29(11):949-55. PubMed ID: 18836372
[TBL] [Abstract][Full Text] [Related]
14. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans.
Wei JP; Burke GJ; Mansberger AR
Ann Surg; 1994 May; 219(5):568-72; discussion 572-3. PubMed ID: 8185405
[TBL] [Abstract][Full Text] [Related]
15. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
Powell DK; Nwoke F; Goldfarb RC; Ongseng F
Clin Imaging; 2013; 37(3):475-9. PubMed ID: 23102932
[TBL] [Abstract][Full Text] [Related]
16. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
[TBL] [Abstract][Full Text] [Related]
17. Sestamibi/iodine subtraction single photon emission computed tomography in reoperative secondary hyperparathyroidism.
Neumann DR; Esselstyn CB; Madera AM
Surgery; 2000 Jul; 128(1):22-8. PubMed ID: 10876181
[TBL] [Abstract][Full Text] [Related]
18. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
[TBL] [Abstract][Full Text] [Related]
19. Presurgical localization of abnormal parathyroid glands using a single injection of Tc-99m sestamibi: comparison of high-resolution parallel-hole and pinhole collimators, and interobserver and intraobserver variation.
Arveschoug AK; Bertelsen H; Vammen B
Clin Nucl Med; 2002 Apr; 27(4):249-54. PubMed ID: 11914663
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-sestamibi/pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism.
Berczi C; Mezõsi E; Galuska L; Varga J; Bajnok L; Lukács G; Balázs G
Eur Radiol; 2002 Mar; 12(3):605-9. PubMed ID: 11870476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
